enilconazole has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alarcan, J; Braeuning, A; de Sousa, G; Gioutlakis, M; Katsanou, ES; Konstantinidou, P; Lampen, A; Lichtenstein, D; Luckert, C; Machera, K; Milani, ES; Peijnenburg, A; Rahmani, R; Rijkers, D; Spyropoulou, A; Stamou, M; Stoopen, G; Sturla, SJ; Wollscheid, B; Zucchini-Pascal, N | 1 |
Amaike, Y; Hosaka, T; Kano, M; Sasaki, T; Shizu, R; Tsuruta, S; Yoshimaru, S; Yoshinari, K | 1 |
2 other study(ies) available for enilconazole and Liver Neoplasms
Article | Year |
---|---|
An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitro.
Topics: Adverse Outcome Pathways; Animals; Cell Line, Tumor; Cell Survival; Drug-Related Side Effects and Adverse Reactions; Fatty Liver; Gene Expression; Hep G2 Cells; Humans; Imidazoles; Liver; Liver Neoplasms; Pesticides; Receptors, Cytoplasmic and Nuclear; Risk Assessment; Triglycerides | 2020 |
Acceleration of murine hepatocyte proliferation by imazalil through the activation of nuclear receptor PXR.
Topics: Animals; Carcinogens; Cell Proliferation; Constitutive Androstane Receptor; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Food Additives; Hep G2 Cells; Hepatocytes; Humans; Imidazoles; Ki-67 Antigen; Liver Neoplasms; Male; Membrane Proteins; Mice, Inbred C57BL; Minichromosome Maintenance Complex Component 2; Pregnane X Receptor; Pyridines; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; RNA, Messenger | 2018 |